News > Covaxin demand grows among Indians after efficacy results

Covaxin demand grows among Indians after efficacy results

India Updates | 10/03/2021 09:07 AM | Click to read full article

As India’s vaccination drive against Covid-19 gathers momentum, the clouds of initial hesitancy about receiving Covaxin, developed by Hyderabad-based Bharat Biotech, has now cleared, raising demand and acceptability of the country’s first indigenous vaccine against the disease.

While a major boost to the vaccine’s acceptability came after Prime Minister Narendra Modi received the first dose of the vaccine earlier this month, the publication of efficacy results gave the vaccine another shot in the arm.